Gauri Deb, Alicia Benítez Rondán, Kelven Burnett, Hugo Olmedo, Pako Lopez Acosta, Ana Isabel Moreno Bernal, Steven Nguyen, Paola Castiglioni, Suzanne Coberly, Carla Guarinos, Lynda Groocock, Rama Krishna Narla, Antonia Lopez-Girona, Soraya Carrancio, Neil Bence. "BMS-986458, a first-in-class, highly selective, and potent ligand-directed degrader (LDD) of B-cell lymphoma 6 (BCL6) combined with T-cell engagers (TCEs) demonstrates preclinical synergistic antitumor efficacy for the treatment of B-cell non-Hodgkin lymphoma (NHL)." Blood (2025). https://doi.org/10.1182/blood-2025-5090